Inside of a current research, we described the identification as well as the characterization of a new atypical opioid receptor with unique adverse regulatory properties towards opioid peptides.1 Our final results showed that ACKR3/CXCR7, hitherto known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is usually a broad-spectrum